APGE Apogee Therapeutics, Inc.
Healthcare$81.16-1.54%ClosedMarket Cap: $5.02B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$109.44
Target (Median)
$103.00
Target Range
$83.00 - $140.00
Upside from current price: 34.8%
Rating Distribution
0 Strong Buy15 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-30 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-24 | Guggenheim | maintain | Buy | Buy |
| 2026-03-24 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-03-24 | Citigroup | maintain | Buy | Buy |
| 2026-03-23 | BTIG | maintain | Buy | Buy |
| 2026-03-03 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-03 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-01-22 | RBC Capital | downgrade | Sector Perform | Outperform |
| 2026-01-06 | BTIG | maintain | Buy | Buy |
| 2025-11-03 | RBC Capital | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-5.41 | $4.2M | 11 |
| Sun Dec 31 | $-6.36 | $5.6M | 12 |
| Mon Dec 31 | $-5.96 | $187.7M | 10 |
| Tue Dec 31 | $-1.01 | $824.4M | 5 |